ArticleMarine drugs2018
Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium
Article in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Molecular-networking-based characterization of cytotoxic metabolites produced by the cyanobacterium Nostoc edaphicum CCNP1411.Molecular diversity · 2026Article
- Next-Generation Cyanobacterial Biocontrol Agents for Crop Fungal Diseases: Molecular Mechanisms, Omics Insights, Applications, and Biosafety Considerations.Journal of basic microbiology · 2026Review
- Discovery of Suomilide and Cyanopeptolin Analogues byJournal of natural products · 2026Article
- Cytotoxic Activity of the Baltic CyanobacteriumToxins · 2025Article
- Characterization of the Tychonamide Biosynthetic Pathway in the Recently Described Cyanobacterial SpeciesACS chemical biology · 2025Article
- Chemical diversity of cyanobacterial natural products.Natural product reports · 2025Review
- Unlocking the biotechnological potential of Baltic microorganisms.Frontiers in microbiology · 2025Review
- Lesser-Known Cyanotoxins: A Comprehensive Review of Their Health and Environmental Impacts.Toxins · 2024Review
- Recent biotechnological applications of value-added bioactive compounds from microalgae and seaweeds.Botanical studies · 2024Review
- Structural Diversity and Biological Activity of Cyanopeptolins Produced byMarine drugs · 2023Article
- Microbial community structure and exploration of bioremediation enzymes: functional metagenomics insight into Arabian Sea sediments.Molecular genetics and genomics : MGG · 2023Article
- In Silico Analysis of a GH3 β-Glucosidase fromMicroorganisms · 2023Article
- Four new suomilides isolated from the cyanobacteriumFrontiers in microbiology · 2023Article
- Anabaenopeptins fromInternational journal of environmental research and public health · 2022Article
- Nostocyclopeptides as New Inhibitors of 20S Proteasome.Biomolecules · 2021Article
- Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.Biomolecules · 2021Article
- Review
- Article
- Bioactive Peptides Produced by Cyanobacteria of the GenusMarine drugs · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detected in the cyanobacterium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.